Several Wall Street firms have cut ahead in line for the H1N1 vaccine ahead of those who really need it.
Yesterday the Center for Responsibility and Ethics in Washington (CREW) asked Health and Human Services (HHS) Secretary Kathleen Sebelius to investigate why the Center for Disease Control (CDC) approved distribution of the vaccine to the Wall Street firms when the vaccine is unavailable to most Americans.
The among the 13 firms that received the vaccine are:
- Goldman Sachs
- JP Morgan Chase